Mateus Vailant Thomazella

Mateus Vailant Thomazella

Auto-generated profile, based on publicly available information

Mateus Vailant Thomazella

Laboratório de Imunologia Clínica e Alergia (LIM60), Hospital das Clínicas HCFMUSP

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Experimental Parasitology
Verified
Journal Article
Closed access
IDIZABEL GALHARDO DEMARCHI
IZABEL GALHARDO DEMARCHI
MTMateus Vailant Thomazella
Mateus Vailant Thomazella
MTMariana de Souza Terron
Mariana de Souza Terron
LLLilian Lopes
Lilian Lopes
ZGZilda Gazim
Zilda Gazim
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni

23 December 2015 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
IDIZABEL GALHARDO DEMARCHI
IZABEL GALHARDO DEMARCHI
MTMariana de Souza Terron
Mariana de Souza Terron
MTMateus Vailant Thomazella
Mateus Vailant Thomazella
CMCamila Alves Mota
Camila Alves Mota
ZGZilda Gazim
Zilda Gazim
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni

30 March 2020 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
FJFernando A. Jorge
Fernando A. Jorge
MTMateus V. Thomazella
Mateus V. Thomazella
DMDeborah de Castro Moreira
Deborah de Castro Moreira
LLLuciana D. G. Lopes
Luciana D. G. Lopes
JTJorge J. V. Teixeira
Jorge J. V. Teixeira
DBDennis Bertolini
Dennis Bertolini

15 September 2023 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
CWCornelia A M van de Weg
Cornelia A M van de Weg
MTMateus V Thomazella
Mateus V Thomazella
MMMariana P Marmorato
Mariana P Marmorato
CCCarolina A Correia
Carolina A Correia
JDJuliana Z C Dias
Juliana Z C Dias
EKEsper G Kallás
Esper G Kallás
In 2018 there was a large yellow fever outbreak in São Paulo, Brazil, with a high fatality rate. Yellow fever virus can cause, among other symptoms, hemorrhage and disseminated intravascular coagulation, indicating a role for endothelial cells in disease pathogenesis. Here, we conducted a case-control study and measured markers related to endothelial damage in plasma and its association with mortality. We found that angiopoietin 2 is strongly associated with a fatal outcome and could serve as a predictive marker for mortality. This could be used to monitor severe cases and provide care to improve disease outcome.

1 October 2019 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
CSClaudinei Mesquita da Silva
Claudinei Mesquita da Silva
LPLeyde Daiane de Peder
Leyde Daiane de Peder
MTMateus Vailant Thomazella
Mateus Vailant Thomazella
JTJorge Juarez Vieira Teixeira
Jorge Juarez Vieira Teixeira
DBDennis Bertolini
Dennis Bertolini
BACKGROUND: Hepatitis B and C virus (HBV and HCV) are the two most common infections among human immunodeficiency virus (HIV)-infected patients. OBJECTIVE: To identify the frequency of HIV subtypes and HCV genotypes in HIV-coinfected patients. METHODS: A cross-sectional and retrospective study was carried out into two reference centers in Southern Brazil between January 1, 2002 and June 30, 2016. The Abbott Real Time HCV Genotype II system was used for routine diagnostics to determine the HCV genotype based on dual-target real-time PCR. Proviral HIV-1 RNA was extracted from serum samples and fragments of the pol gene were generated by PCR. The HIV-1 PT and RT gene sequences were submitted to Maximum Likelihood Phylogenetic analysis by collecting reference sequences from the HIV-1 group M subtype of the Los Alamos database. RESULTS: During the study period, 3340 patients with HIV were diagnosed at both referral centers, of which 4.97% (166/3340) had HBV and/or HCV coinfection. Seroprevalence of HIV-HBV, HIV-HCV and HIV-HBV-HCV was 37.4%, 58.4%, and 4.2%, respectively. HIV-HCV-coinfected patients had a lower median nadir CD4+ T-cell count when compared to HIV-HBV-coinfected patients (P=0.01). Among those coinfected with HCV, HCV-1 (HCV-1) and HCV-3 (HCV-3) genotypes were the most prevalent, being detected in 73.8% and 21.4%, respectively. Among the HCV-1 coinfected patients, 79.3% and 20.1% had subtypes 1a and 1b, respectively. HIV subtype B was the most prevalent in HIV-coinfected patients. There was no significant difference regarding nadir CD4+ T-cell count and HIV viral load when compared to coinfected with HCV-1 with HCV-3, as well as those co-infected with HCV-1a with HCV-1b. CONCLUSION: In the present study, a higher frequency of subtype B of HIV and HCV-1 were found in HIV-coinfected patients. Further larger-scale and long-term studies are needed to better understand the effect of HCV genotypes in HIV-infected patients.

14 September 2015 in Flavour and Fragrance Journal
Verified
Journal Article
Closed access
PDF file
IDIZABEL GALHARDO DEMARCHI
IZABEL GALHARDO DEMARCHI
MTMariana D‐S. Terron
Mariana D‐S. Terron
MTMateus V. Thomazella
Mateus V. Thomazella
RPRaíssa B. Pedroso
Raíssa B. Pedroso
ZGZilda Gazim
Zilda Gazim
MLMaria V. C. Lonardoni
Maria V. C. Lonardoni